AI Integration in the Fight Against Age-Related Macular Degeneration

In this interview, Wen Hwa Lee, CEO, and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), offers an enlightening perspective on merging AI with ophthalmology to forge new paths in healthcare and drug discovery.

Related Keywords

Wen Hwa Lee ,Danielle Ellis ,Data Institute ,University Of Oxford ,United Kingdom Ltd Jan ,Structural Genomics Consortium ,Hub Data Trust Advisory Board ,Sponsored Content ,United Kingdom ,Ltd Jan ,Chief Scientist ,Action Against Age Related Macular Degeneration ,Action Against ,Wen Hwa ,Image Credit ,European Lead ,Data Trust Advisory Board ,Open Data Institute ,Age Related Macular Degeneration ,Macular Degeneration ,Charity ,Drug Discovery ,Genomics ,Healthcare ,Medicine ,Ophthalmology ,Research ,Structural Biology ,